EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cellular immunity in the era of modern multiple myeloma therapy

Zhaoyun Liu, Xianghong Zhao, Hongli Shen, Xiaohan Liu, Xintong Xu, Rong Fu iD

International Journal of Cancer · 15.10.2023 · 153 (8) · 1436-1447

DOI: 10.1002/ijc.34609 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Cancer, online erschienen am 12.06.2023. Verfasst von Zhaoyun Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tianjin Medical University General Hospital, Heping District, Tianjin, China. Hauptthemen laut MEDLINE: Multiple Myeloma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 179 Literaturangaben. Gefördert von: Tianjin Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma ( MM ) is a relapsing clonal plasma cell malignancy and incurable thus far. With the increasing understanding of myeloma, highlighting the critical importance of the immune system in the pathogenesis of MM is essential. The immune changes in MM patients after treatment are associated with prognosis. In this review, we summarize currently available MM therapies and discuss how they affect cellular immunity. We find that the modern anti‐MM treatments enhance antitumour immune responses. A deeper understanding of the therapeutic activity of individual drugs offers more effective treatment approaches that enhance the beneficial immunomodulatory effects. Furthermore, we show that the immune changes after treatment in MM patients can provide useful prognostic marker. Analysing cellular immune responses offers new perspectives for evaluating clinical data and making comprehensive predictions for applying novel therapies in MM patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaHumansImmunotherapyNeoplasm Recurrence, LocalPlasma CellsImmunity, Cellular

Stichwörter der Autor:innen

cellular immunityclinical trialimmunological changeimmunomodulatormultiple myeloma

Autor:innen und Institutionen

  • Department of Hematology, Tianjin Medical University General Hospital, Heping District, Tianjin, China.

ORCID-Profile: Rong Fu

Förderung

  • Tianjin Science and Technology Program

Zitieren

APA

Liu, Z., Zhao, X., Shen, H., Liu, X., Xu, X., & Fu, R. (2023). Cellular immunity in the era of modern multiple myeloma therapy. International Journal of Cancer, 153(8), 1436-1447. https://doi.org/10.1002/ijc.34609

Vancouver

Liu Z, Zhao X, Shen H, Liu X, Xu X, Fu R. Cellular immunity in the era of modern multiple myeloma therapy. International Journal of Cancer. 2023;153(8):1436-1447. doi:10.1002/ijc.34609

BibTeX
@article{Liu2023,
  author = {Liu, Zhaoyun and Zhao, Xianghong and Shen, Hongli and Liu, Xiaohan and Xu, Xintong and Fu, Rong},
  title = {Cellular immunity in the era of modern multiple myeloma therapy},
  journal = {International Journal of Cancer},
  year = {2023},
  volume = {153},
  number = {8},
  pages = {1436--1447},
  doi = {10.1002/ijc.34609}
}
Kostenlos starten →